Kallikrein-thrombolytic and hypotensive action in cats - preliminary results

• Autorzy: Swies J. , Grodzinska L. , Slawinski M. , Gryglewski R.J.
• Języki publikacji: EN

Abstrakty

EN

Święs J., Grodzińska L., Sławiński M., Gryglewski R. J.: Kallikrein-thrombolytic and hypotensive action in cats - preliminary results. Acta Physiol. Pol. 1990, 41 (1-3): 87-95. An intravenous injection of kallikrein produced hypotensive and thrombolytic effects in anasthetized cats, using the blood superfused tendon technique. The thrombolytic action of kallikrein was mediated by an unstable substance. The generation of this substance was abolished by either acetylsalicylic acid (ASA) or aprotonin and enhanced by captopril. The hypotensive action of kallikrein was only partially inhibited by ASA. It is proposed that both these pharmacological effects of kallikrein are mediated by bradykinin which in turn releases prostacyclin from the endothelium. However, in contrast to the thrombolytic effect of kallikrein which is totally mediated by prostacyclin the hypotensive action of kallikrein depends not only on prostacycylin but also on another endothelium-derived vasorelaxant, e.g. EDRF.

Słowa kluczowe

EN

kallikrein; bradykinin; prostacyclin; thrombolytic activity; hypotensive action; cat

• Wydawca: -
• Czasopismo: Acta Physiologica Polonica
• Rocznik: 1990
• Tom: 41
• Numer: 1-3
• Opis fizyczny: p.87-95,fig.,ref.

Twórcy

autor

Swies J.

• Department of Pharmacology, N.Copernicus Academy of Medicine, Krakow, Poland

autor

Grodzinska L.

• Department of Pharmacology, N.Copernicus Academy of Medicine, Krakow, Poland

autor

Slawinski M.

• Department of Pharmacology, N.Copernicus Academy of Medicine, Krakow, Poland

autor

Gryglewski R.J.

• Department of Pharmacology, N.Copernicus Academy of Medicine, Krakow, Poland

Bibliografia

• 1. Azuma H., Ishikawa M., Sekizaki S. (1986). Endothelium-dependent inhibition of platelet aggregation. Brit. J. Pharmacol., 88, 411-415.
• 2. Bergamaschi M., Glasser A. H. (1964). Peripheral vasodilator action of eledoisin, bradykinin and nitroglycerin in anaesthetized dogs. Circ. Res., 15, 371-379.
• 3. Blumberg A. M., Denny S. E., Marshall G. R., Needleman P. (1977). Blood vessel hormone interaction: angiotensin, bradykinin and prostaglandins. Am. J. Physiol., 232, H3O5-H31O.
• 4. Chand N., Ahura В. M. (1981). Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. Science, 23, 1376-1379.
• 5. Cushman D., Cheung H. S., Sabo E. G., Ondetti M. A. (1977). Design of potent competitive inhibitor of angiotensin-converting enzyme Carboxy alkanyol and mercaptoalkanoyl amino acids. Biochemistry, 16, 5484-5491.
• 6. Dembińska-Kieć A., Kostka-Trąbka E., Gryglewski R. J. (1982). Effect of prostacyclin on fibrynolytic activity in patients with arteriosclerosis obliterans. Thromb. Haemostas., 47, 190-196.
• 7. Fösterman U., Neufang В. (1984). The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur. J. Pharmacol., 103, 65-70.
• 8. Furchgott R. F. A. (1984). The role of endothelium in the response of vascular smooth muscle to drugs. Rev. Pharmacol., 24, 175-197.
• 9. Furchgott R. F., Zawadzki J. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 272-276.
• 10. Gordon J. L., Martin W. (1983). Endothelium-dependent relaxation the pigs aorta: relationship to stimulation of ⁸⁶ Rb efflux from isolated endothelial cells. Brit. J. Pharmacol., 79, 531-541.
• 11. Gorog P., Kovacs J. B. (1986). Prostacyclin is a more potent stimulator of thrombolysis than inhibitior of haemostasis. Haemostasis, 16, 337-345.
• 12. Grozinger A. H. (1980). Kombinierte medikamentose Behandlung arterieller Durchblutun- gotorungen. Med. Welt, 29, 784-789.
• 13. Gryglewski R. J. (1987). The impact of prostacyclin studies on the development of its stable analogoes. In: Prostacyclin and its stable analogue L Iloprost. Eds. Gryglewski R. J., Stock G., Springer Verlag, Berlin, pp. 3-16.
• 14. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. (1976). Arterial walls are protected against deposition of platelet thrombi by a substance (Prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins, 12, 685-713.
• 15. Gryglewski R. J., Korbut R., Ocetkiewicz A. (1978a). Reversal of platelet aggregation by prostacyclin. Pharmacol. Res. Commun., 10, 185-189.
• 16. Gryglewski R. J., Korbut R., Ocetkiewicz A., Stachura J. (1978b). In vivo method of quantification of antiplatelet potency of drugs. Naunyn-Schmiedeberg’s Arch. Pharmacol., 302, 25-30.
• 17. Gryglewski R. J., Moncada S., Palmer R. M. J. (1986). Bioassay of prostacyclin and endothelium-derived relaxing factor “EDRF” from porcine aorta endothelial cells. Brit. J. Pharmacol., 87, 685-694.
• 18. Hoffman J. (1982). Bilanz eines kombinierten Einsatzes von Nico-Padutin und Depor-Padutin beu peripherer arterieller Verschlusskrankheit. Med. Welt, 33, 1034-1037.
• 19. Korbut R., Moncada S. (1978). Prostacyclin (PGI₂ ) and thromboxane A₂ interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy. Thromb. Res., 13, 489-500.
• 20. Lumder P. L., Selwyn A. P., Shook T. L., Wayne R. R., Mudge G. H., Wayne A. R., Genz P. (1986). Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. The New Engl. J. Med., 315, 1046-1051.
• 21. Nakano J. (1965). Effect of synthetic bradykinin on the cardiovascular system. Arch. I nt. Pharmacodyn. Ther., 157, 1-13.
• 22. Needleman P., Marshall G. R., Sobel В. E. (1975). Hormone interactions in the isolated rabbit heart. Circ. Res., 37, 802-808.
• 23. Ondetti M. A., Rubin B., Cushman D. W. (1977). Design of inhibitors of angiotensin-converting enzyme. A new class of orally active anty hypertensive agents. Science, 194, 441-444.
• 24. Regoli D., Barabe J. (1980). Pharmacology of bradykinin and related kinins. Pharm. Rev., 32, 1-46.
• 25. Sammeli E., Eskes T. K. A. B. (1962). Bradykinin and cardiovascular system. Estimation of half-life. Amer. J. Physiol., 203, 262-265.
• 26. Schachter M. (1978). Kallikreins (kininogenases) - a group of serine proteases with bioregulatory action. Pharm. Rev., 31, 1-17.
• 27. Utsunomiya T., Krausz M. M., Valeri G. R., Shepro D., Hechtman H. B. (1980). Treatment of pulmonary embolism with prostacyclin. Surgery, 88, 25-30.
• 28. Wei E. P., Kontos H. E., Christman C. W., DeWitt D. S., Povlishok J. T. (1985). Superoxide generation and reversal of acetylcholine-induced cerebral arterioral dilatation after acute hypertension. Circ. Res., 57, 781-787.